权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Georgia Cystic Fibrosis Research and Translation Core Center

乔治亚州囊性纤维化研究与转化核心中心

基本信息

批准号：
10260479
负责人：
NAEL A MCCARTY
金额：
$ 59.01万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-10 至 2023-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10260479
关键词：
Address Aging Basic Science Behavior Behavioral Biomedical Engineering Biomedical Research Center Core Grants Child Child health care Clinical Clinical Informatics Clinical Research Collaborations Communities Cystic Fibrosis Cystic Fibrosis Transmembrane Conductance Regulator Data Development Diabetes Mellitus Direct Costs Disease Disease Progression Elements Ensure Environment Functional disorder Funding Goals Health Homeostasis Informatics Institutes Institution Life Style Link Liver diseases Longitudinal Studies Lung Metabolic Mission Molecular National Institute of Diabetes and Digestive and Kidney Diseases Nutritional Nutritional status Outcome Patients Population Research Research Personnel Research Support Resources Science Scientist Sleep Source Technology Therapeutic Toddler Translations Universities base biomedical scientist comorbidity cystic fibrosis related diabetes diet and exercise gastrointestinal glucose metabolism member multiple omics mutant new therapeutic target novel therapeutic intervention nutrition preventive intervention program dissemination programs small molecule therapeutics success

项目摘要

PROJECT SUMMARY – Overall This application proposes to establish the Georgia Cystic Fibrosis Research and Translation Core Center (the Georgia CF Core Center) at Emory University, Children’s Healthcare of Atlanta, Augusta University, and the Georgia Institute of Technology. This center will leverage activities at these institutions to solve critical problems associated with CF. Georgia CF Core Center research will focus on non-pulmonary aspects of CF disease central to the mission of the NIDDK, including CF-related diabetes (CFRD) and the impact of CF on nutritional status, GI function, and liver disease. Unique to our center will be the study of the relationship between these co-morbidities and lifestyle/behavioral choices such as diet, exercise, and sleep. The proposed basic, clinical, and translational CF research supported via this application is centered around the 900 patients followed at the participating institutions. The research base is comprised of 61 investigators, across both basic and clinical departments at four institutions, with a total of $15,150,207 in direct costs for CF-related research in the current year. These investigators will address issues that are becoming ever more important to the health of people with CF, as successes with small-molecule therapeutics makes it possible for us to anticipate an “aging” CF population. On the opposite end of the spectrum are studies in toddlers and young children on the genesis of these co-morbidities which have the potential for defining early preventive interventions. We will integrate data from multiple platforms spanning from basic science to ‘omics and clinical research informatics to enable longitudinal study of patients with the goal of identifying factors associated with disease progression and advancing our understanding of current CF therapeutic and lifestyle approaches.  Aim 1: To provide a robust, well-coordinated environment for CF biomedical research.  Aim 2: To facilitate and enable the expansion of the funded research in non-pulmonary complications of CF.  Aim 3: To attract new investigators focused on non-pulmonary complications of CF who will bring new expertise that will advance new perspectives on pathophysiology and treatment. We will accomplish these aims by the coordinated activities of four biomedical research Cores:  Diabetes, GI, and Nutrition Core  Lifestyle and Behaviors Core  Molecular Multi-Omics Core  Clinical Research and Informatics Core These research cores will be supported by an Administrative Core which will ensure the efficient use of resources. This core will also strengthen the intellectual environment for research through a robust Enrichment and Dissemination Program as well as a Pilot & Feasibility Program with two projects proposed. Support of the proposed P30 program will create a vigorous research enterprise focused on non-pulmonary CF disease, uncovering new disease mechanisms with potential for translation to therapeutic strategies.

项目概述-整体